Vera Therapeutics (VERA) is up 19.2%, or $6.35 to $39.35.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- These 3 Stocks Have Triple-Digit Upside Potential, Say Five-Star Analysts – 11/26/2025
- Vera Therapeutics Appoints James R. Meyers to Board
- Optimistic Buy Rating for Vera Therapeutics Driven by Atacicept’s Commercial Potential and Favorable Valuation
- Positive Market Outlook for Vera Therapeutics Driven by Atacicept’s Strategic Advantages and Favorable Regulatory Environment
- Buy Recommendation for Vera Therapeutics: Atacicept’s Market Potential and Efficacy Drive Positive Outlook